Abbvie (ABBV) PT Lowered to $211 at Truist Securities; 'We Like Longer-term Outlook for ABBV'
Tweet Send to a Friend
Truist Securities analyst Srikripa Devarakonda lowered the price target on Abbvie (NYSE: ABBV) to $211.00 (from $215.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
